Refine results by
Top countries
Publication dates
All countries
Popular tags
1-30 of 6 467 Premium Reports from 56 Publishers
A brief recession and the devaluation of the local currency have demonstrated that Belarus has not beenable to escape the global economic crisis, although sheer lack of integration into the global financialsystem has done much to blunt its impact. According to BMI, the country?s pharmaceutical secto ...
Industries : Healthcare, Pharmaceutical
We expect total drug spending in Lebanon to increase from under US$500mn in 2008 to US$605mn in2013, a compound annual growth rate (CAGR) of 3.9% in US dollar terms, with 1.75% of GDP dedicatedto pharmaceutical expenditure by 2013.The Minister of Health, Mohammad Jawad Khalifeh, has held the positio ...
Industries : Healthcare, Pharmaceutical
IntroductionCRC incidence will be over 490,000 cases by 2018 in the seven major markets. This large patient base will translate into a high commercial potential for the development of novel, more effective therapies. Currently, there are 77 agents in development for CRC, 4 of which are in late-phase ...
Industries : Therapy
IntroductionThe author expects the Australian antidiabetics market to reach $416m by 2018. The growth will be driven by the launch of new drug classes, notably the incretin mimetics, and large growth in patient numbers. Although strongest growth is expected in the non-insulin market, the insulin ma ...
Industries : Drug and Medication
IntroductionThe author expects the Australian antidiabetics market to reach $416m by 2018. The growth will be driven by the launch of new drug classes, notably the incretin mimetics, and large growth in patient numbers. Although strongest growth is expected in the non-insulin market, the insulin ma ...
Industries : Drug and Medication
IntroductionThe Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. THIS PRODUCT HAS B ...
Industries : Beverage, Pharmaceutical
INDUSTRY RISK RATINGS REPORTThis is the replacement for May 2009 edition of Pharmaceutical & Medicine Manufacturing in the US Industry Risk Ratings Report.Industry Risk Ratings SynopsisThis Industry Risk Ratings report evaluates the inherent risks associated with the Pharmaceutical & Medicine Manu ...
Industries : Pharmaceutical
INDUSTRY RISK RATINGS REPORTThis is the replacement for June 2009 edition of Pharmaceutical Product Manufacturing in Australia Industry Risk Ratings Report.Industry Risk Ratings SynopsisThis Industry Risk Ratings report evaluates the inherent risks associated with the Pharmaceutical Product Manufa ...
Industries : Pharmaceutical
INDUSTRY RISK RATINGS REPORTThis is the replacement for March 2009 edition of Pharmaceuticals Wholesaling in Australia Industry Risk Ratings Report.Industry Risk Ratings SynopsisThis Industry Risk Ratings report evaluates the inherent risks associated with the Pharmaceuticals Wholesaling in Austra ...
Industries : Pharmaceutical, Wholesaling
INDUSTRY RISK RATINGS REPORTThis is the replacement for June 2009 edition of Pharmacies in Australia Industry Risk Ratings Report.Industry Risk Ratings SynopsisThis Industry Risk Ratings report evaluates the inherent risks associated with the Pharmacies in Australia industry. Industry Risk is assu ...
Industries : Pharmaceutical, Pharmacies and Drug Stores
INDUSTRY RISK RATINGS REPORTThis is the replacement for July 2009 edition of Cosmetic and Toiletry Retailing in Australia Industry Risk Ratings Report.Industry Risk Ratings SynopsisThis Industry Risk Ratings report evaluates the inherent risks associated with the Cosmetic and Toiletry Retailing in ...
Industries : Pharmacies and Personal Care Stores, Pharmacies and Drug Stores
INDUSTRY RISK RATINGS REPORTThis is the replacement for July 2009 edition of Contract Packing Services in Australia Industry Risk Ratings Report.Industry Risk Ratings SynopsisThis Industry Risk Ratings report evaluates the inherent risks associated with the Contract Packing Services in Australia i ...
Industries : Pharmaceutical, Chemical
INDUSTRY RISK RATINGS REPORTThis is the replacement for July 2009 edition of Pathology Services in Australia Industry Risk Ratings Report.Industry Risk Ratings SynopsisThis Industry Risk Ratings report evaluates the inherent risks associated with the Pathology Services in Australia industry. Indus ...
Industries : Pathology
According to the chain drug stores ranking in China in 2009, top 100 enterprises in China pharmaceutical chain industry achieved the sales revenue of RMB57.24 billion in 2008, increasing by RMB13.33 billion (30.35%) than RMB43.91 billion in 2007. In 2008, the average profit margin of top 100 enterp ...
Industries : Pharmaceutical
From BHD44mn (US$114mn) in 2008, BMI forecasts that Bahrain?s pharmaceutical market will expandto be worth BHD61mn (US$160mn) in 2018. While the market will remain small in absolute terms, rapidvalue growth, representing a compound annual growth rate (CAGR) of 6.8% and a favourable politicaleconomic ...
Industries : Healthcare, Pharmaceutical
In BMI?s view, China is arguably the most attractive emerging pharmaceutical market. Though to 2013,we are forecasting a compound annual growth rate (CAGR) of 15.45%. Annual per-capita spending willrise from US$27.60 to US$54.40. Spending as a percent of GDP is expected to increase from 0.97% to1.16 ...
Industries : Healthcare, Pharmaceutical
BMI calculates that pharmaceutical sales in Portugal reached EUR3.61bn (US$5.31bn) in 2008. Wecalculate that the sales of prescription and over-the-counter (OTC) medicines will reach a value ofEUR0.302bn by 2013, equating to a constant annual growth rate (CAGR) of 2.79% in local currencyterms. We no ...
Industries : Healthcare, Pharmaceutical
IntroductionThis analysis examines the historical and forecast performance for GSK in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An inte ...
Industries : Pharmaceutical
BMI calculates that Lithuania?s pharmaceutical market reached a value of LTL1.70bn (US$0.70bn) in2008. By 2013, we expect the value of the prescription and over-the-counter (OTC) markets to reach avalue of LTL2.13bn, equating to a compound annual growth rate (CAGR) of 4.61% over the forecastperiod. ...
Industries : Healthcare, Pharmaceutical
We expect the value of the total pharmaceutical market to increase from US$2.5bn in 2008 to US$4.2bnby 2013, representing a compound annual growth rate (CAGR) of 10.8% in US dollar terms and 8.6% inlocal currency. Per-capita spending on medicines will reach 81.6% by this time while only 0.89% of GDP ...
Industries : Healthcare, Pharmaceutical
BMI calculates that pharmaceutical sales in Venezuela reached VEB7.5bn (US$3.57bn) in 2008. By2013, we forecast the Venezuelan pharmaceutical market will be worth VEB26.0bn, increasing at acompound annual growth rate (CAGR) of 28.23%. BMI notes that as a result of the weakeningVenezuelan bolivar, d ...
Industries : Healthcare, Pharmaceutical
The Generics: Global Industry Guide is an essential resource for top-level data and analysis covering the Generics industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive ...
Industries : Generic Drug
Snapdata's Snapshots Australia Pharmaceuticals 2009 provides 2007 year-end market size data, with 2008 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the Australian pharmaceutical market and covers Ethical and OTC drugs. Market value ...
Industries : Pharmaceutical
Snapdata's Snapshots Bulgaria Pharmaceuticals 2009 provides 2007 year-end market size data, with 2008 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the Bulgarian pharmaceutical market and covers prescription and OTC pharmaceuticals. ...
Industries : Pharmaceutical
Snapdata's Snapshots France Pharmaceuticals 2009 provides 2007 year-end market size data, with 2008 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the French pharmaceutical market and covers refundable, non-refundable and hospital us ...
Industries : Pharmaceutical
BMI calculates that pharmaceutical sales in Peru reached PEN2.58bn (US$0.88bn) in 2008. Thisrepresents impressive growth of 8.5% in local currency terms between 2007 and 2008. However, BMI?sforecast for 2009 is more conservative and we calculate that the drug market will experience growth of5.4%, re ...
Industries : Healthcare, Pharmaceutical
This quarter BMI introduces 10-year forecasts for the Russian pharmaceutical markets, providing anopportunity to look beyond the current financial crisis and assess the growth potential for the largest andmost populous pharmaceutical market in Central and Eastern European (CEE). By 2018, we forecast ...
Industries : Healthcare, Pharmaceutical
In BMI?s Business Environment Ratings for Q409, Spain remains placed fourth out of the nine WesternEuropean Markets surveyed. Spain?s large and generously subsidised drug market, low genericpenetration, ageing population and stable economic and political system mean that it scores highlycompared wit ...
Industries : Healthcare, Pharmaceutical
In BMI?s Business Environment Ratings (BER) for Q409, the UK improved its position by one place,and is now ranked 5th of the 9 Western European markets surveyed. However, while the UK is one of themost developed pharmaceutical markets in the world, pressing economic and political issues ? as well as ...
Industries : Healthcare, Pharmaceutical
Despite a downturn in growth rates in the US pharmaceuticals & healthcare markets, the country remainsa core component for any company looking to achieve global success. Healthcare spending in 2008reached US$2.3trn, while sales of pharmaceuticals topped US$309bn.For BMI?s US Pharmaceuticals & Health ...
Industries : Healthcare, Pharmaceutical
reportlinker.com © Copyright 2009. All rights reserved